Sartorius Aktiengesellschaft (ETR:SRT3)
Germany · Delayed Price · Currency is EUR | Market Cap | 15.08B |
| Revenue (ttm) | 3.52B |
| Net Income (ttm) | 133.60M |
| Shares Out | 69.04M |
| EPS (ttm) | n/a |
| PE Ratio | 112.88 |
| Forward PE | 73.30 |
| Dividend | 0.74 (0.31%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 25,361 |
| Average Volume | 135,595 |
| Open | 242.70 |
| Previous Close | 241.30 |
| Day's Range | 239.50 - 242.80 |
| 52-Week Range | 166.05 - 292.00 |
| Beta | 1.24 |
| RSI | 70.82 |
| Earnings Date | Jan 29, 2026 |
About ETR:SRT3
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy... [Read more]
Financial Performance
In 2024, ETR:SRT3's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.
Financial StatementsNews
7 Stocks Taking The Next Step To Be On Offense
Bio-Rad Laboratories was a positive contributor after the company reported steadier earnings than the market expected. PVH also remains our largest share repurchaser for the year after buying a teens ...
It's time to scoop up undervalued stocks in this critical sector of the economy
Expanding your horizons and considering neglected sectors can help you identify bargain opportunities while defending your investment portfolio from a stock-market decline.
Sartorius Aktiengesellschaft (SOAGY) Q3 2025 Earnings Call Transcript
Sartorius AG (SARTF) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Improved ...
Sartorius AG (SARTF) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Improved Margins Amid FX Challenges
Sartorius (SARTF) Reports Q3 Earnings and Updates Full-Year Outlook
Sartorius (SARTF) Reports Q3 Earnings and Updates Full-Year Outlook
Sartorius (SARTF) Boosts Growth Outlook After Strong Q3 Performance
Sartorius (SARTF) Boosts Growth Outlook After Strong Q3 Performance
Q3 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript
Q3 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript
Sartorius boosts U.S. life sciences stocks after guidance hike
U.S. life sciences stocks rise as industry bellwether Sartorius (SARTF) raises revenue outlook citing strong YTD results. Read more here.
Sartorius Aktiengesellschaft 2025 Q3 - Results - Earnings Call Presentation
2025-10-16. The following slide deck was published by Sartorius Aktiengesellschaft in conjunction with their 2025 Q3 earnings call.
Salesforce mit neuen Plänen, TSMC stark, Morgan Stanley toppt Erwartungen • news
FlatexDeGiro, Sartorius, Abbott Laboratories, Bank of America, Morgan Stanley, United Airlines, Apple, Nvidia, Arm, Hims & Hers, Salesforce, Taiwan Semi.
DAX Down Slightly; Sartorius Soars 10% On Strong Sales Forecast
(RTTNews) - German stocks are turning in a mixed performance on Thursday as investors largely stay cautious amid a lack of fresh data, and await earnings updates and continue to monitor political deve...
Sartorius Shares Rise After Guidance Lift
Sartorius said it now expects 7% revenue growth for 2025, compared with 6% previously, as underlying net profit rose 17%.
Sartorius (SARTF) Reports Strong Q3 Growth and Updates Forecast
Sartorius (SARTF) Reports Strong Q3 Growth and Updates Forecast
Sartorius Aktiengesellschaft GAAP EPS of €0.63, revenue of €843.2M; updates FY outlook
Sartorius Vz. Boosts Outlook on Strong 9-Month Profit Surge
Sartorius shines with a 7.5% sales surge and 13% EBITDA boost, driven by Bioprocess Solutions' growth and Lab Products' resilience, forecasting a promising year ahead. Jetzt den vollständigen Artikel ...
EQS-News: Sartorius sharpens guidance after significantly profitable sales revenue growth in the first nine months
EQS-News: SARTORIUS AG / Key word(s): 9 Month figures Sartorius sharpens guidance after significantly profitable sales revenue growth in the first nine months (news with additional features) 16.10.202...
Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™
Delray Beach, FL,, Oct. 08, 2025 (GLOBE NEWSWIRE) -- formation, and contamination risks threaten sample viability. Ensuring consistent global transportation standards will be a key differentiator for ...
Sartorius Aktiengesellschaft 2025 Q2 - Results - Earnings Call Presentation
The following slide deck was published by Sartorius Aktiengesellschaft in conjunction with their 2025 Q2 earnings call.
Sartorius Aktiengesellschaft (SARTF) Q2 2025 Earnings Call Transcript
Sartorius (SARTF) Posts Strong 1H Earnings and Confirms 2025 Guidance
Sartorius (SARTF) Posts Strong 1H Earnings and Confirms 2025 Guidance
Sartorius Aktiengesellschaft GAAP EPS of €2.44, revenue of €1.77B; reaffirms FY outlook
Sartorius Earnings Soar Amid Continued Growth Surge
Sartorius marked the first half of 2025 with impressive financial strides, driven by strategic growth in its Bioprocess Solutions Division and a solid profit increase. Jetzt den vollständigen Artikel ...
EQS-News: Sartorius continues growth course; earnings rise at a significantly overproportionate rate
EQS-News: SARTORIUS AG / Key word(s): Half Year Results Sartorius continues growth course; earnings rise at a significantly overproportionate rate (news with additional features) 22.07.2025 / 07:00 CE...
EQS-DD: Sartorius AG: Dr. Michael Große, Transfer of 6,353 preference shares as a share-based remuneration component in fulfillment of a grant made before the start of the Management Board mandate.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 04.07.2025 / 14:26 CET/CEST The issuer is solely responsi...
EQS-DD: Sartorius AG: Dr. Michael Große, Transfer of 7,741 ordinary shares as a share-based remuneration component in fulfillment of a grant made before the start of the Management Board mandate.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 04.07.2025 / 14:19 CET/CEST The issuer is solely responsi...